Dr. Paul Hahn, a New York City native and pioneering eye surgeon, returned
to the northeast in 2016 to join the medical staff at Clara Maass Medical
Center and the advanced eye care team at NJRetina.
Dr. Hahn attended Harvard University where he was awarded the Detur Prize
for Academic Achievement of the Highest Distinction – awarded to
top 5-10% of first- year students based on academic merit—the John
Harvard Scholarship for academic excellence. He then graduated magna cum
laude from Harvard University with a degree in Biochemical Sciences. He
then followed in the footsteps of his father and grandfather, who were
both ophthalmologists, and completed his medical education at the University
of Pennsylvania School of Medicine. He was sponsored by the National Institute
of Health for completion of his MD, along with a PhD degree in molecular
pharmacology investigating novel treatment pathways for dry age-related
macular degeneration. Dr. Hahn then completed his ophthalmology residency
at the Scheie Eye Institute at the University of Pennsylvania, followed
by a two-year fellowship in vitreoretinal diseases and surgery at Duke
After he completed his fellowship, Dr. Hahn remained at Duke University
as an Assistant Professor of Ophthalmology at Duke’s medical school
for nearly four years, where he gained experience in managing the full
range of eye conditions, including the most complex of complications.
As a surgeon at Duke University Eye Center, Dr. Hahn developed an interest
in next-generation treatments and cutting edge technologies. This led
him to found the Duke Center for Artificial and Regenerative Vision, where
he served as director. It was here that Dr. Hahn first implanted the Argus
II—a retinal prosthesis system that is often called a bionic eye.
This was the first robotic eye ever implanted in the Southeast, and only
the seventh time it had been done in the entire United States. The surgery
helps restore vision in people with the degenerative disease retinosa
pigmentosa. This groundbreaking surgery caught the attention of local,
national, and international media, with stories about Dr. Hahn’s
pioneering surgery published around the world. Watch now:
He has Dr. Hahn has published more than 50 peer-reviewed articles and book
chapters and served as principal investigator for multiple clinical trials.
He has lectured at numerous national and international meetings on topics
including macular degeneration, diabetic retinopathy, retinal vascular
disease, retinal detachment, macular hole, epiretinal membrane, ocular
imaging, and advanced surgical techniques. He has also supervised and
provided expert guidance for complex surgeries in the United States and
around the world. He has remained active as a consultant and advisory
board member for major surgical and therapeutic companies and serves on
the editorial board of multiple ophthalmic journals, including as a serving
member of the American Society of Retina Specialists – Research
and Safety in Therapeutics Committee. He has been the invited participant
of American Academy of Ophthalmology Board of Trustees strategic retreat
and selected participant of Heed Ophthalmic Foundation annual retreat.
Dr. Hahn has also been the recipient of numerous prestigious honors and
awards for excellence in ophthalmology research, receiving the Dr. William
F. Jeffers Prize, Association of University Professors of Ophthalmology
/Research to Prevent Blindness Resident and Fellow Research Award, Ronald
G. Michels Foundation Fellowship, the Heed Foundation Fellowship, and
the American Society of Retinal Specialists Honor Award.
Dr. Hahn is married and has two daughters. He spends most of his free time
with his young family, but also enjoys playing golf and is a car enthusiast.